Parkinson's Disease

Parkinson's disease is a brain disorder. It occurs when certain nerve cells (neurons) in a part of the brain called the substantia nigra die or become impaired. When approximately 80 percent of neurons are damaged, the symptoms of Parkinson's disease appear. Parkinson's disease affects 1 in 100 people over the age of 60, with the average age of onset being 60 years. The risk of developing Parkinson's disease increases with age. In the United States, it is estimated that 60,000 new cases of Parkinson's disease are diagnosed each year, with 1.5 million Americans currently living with the disease.

Overview

Feature Articles

Latest Parkinson's Disease News and Research

Non-invasive ultrasound therapy targets brain disorders, offers hope

Non-invasive ultrasound therapy targets brain disorders, offers hope

New research explores how antimicrobial exposure affects Parkinson’s disease risk

New research explores how antimicrobial exposure affects Parkinson’s disease risk

Human midbrain organoids: A promising tool in the fight against Parkinson's disease

Human midbrain organoids: A promising tool in the fight against Parkinson's disease

Researchers identify genetic links to brain volume and disorders

Researchers identify genetic links to brain volume and disorders

New clinical model can accurately predict hip fracture risk in the elderly

New clinical model can accurately predict hip fracture risk in the elderly

Computational tools unlock the secrets of the genome

Computational tools unlock the secrets of the genome

Innovative nanodiscs offer less invasive method for deep brain stimulation

Innovative nanodiscs offer less invasive method for deep brain stimulation

New magnetogenetics technology holds promise as a powerful tool for studying the brain

New magnetogenetics technology holds promise as a powerful tool for studying the brain

Replicating Lewy body formation in living neurons to understand Parkinson's disease

Replicating Lewy body formation in living neurons to understand Parkinson's disease

Study reviews BNMs' role in understanding brain disorders

Study reviews BNMs' role in understanding brain disorders

Collaborative study investigates underlying cause of neuropsychiatric symptoms in Parkinson's disease

Collaborative study investigates underlying cause of neuropsychiatric symptoms in Parkinson's disease

Study identifies ophthalmic acid as an alternative to dopamine in motor control

Study identifies ophthalmic acid as an alternative to dopamine in motor control

New method harnesses light to activate neurons in the brain

New method harnesses light to activate neurons in the brain

NYU Langone secures NIH award to explore eye imaging for early detection of Alzheimer's and Parkinson's

NYU Langone secures NIH award to explore eye imaging for early detection of Alzheimer's and Parkinson's

NIH grant supports research on cognitive decline in individuals with Lewy body diseases

NIH grant supports research on cognitive decline in individuals with Lewy body diseases

Speech recognition technology shows significant gains for people with dysarthria

Speech recognition technology shows significant gains for people with dysarthria

Computational study identifies spinal circuit that modulates stretch reflexes

Computational study identifies spinal circuit that modulates stretch reflexes

Purine metabolism disruptions highlighted as crucial in Parkinson’s disease development

Purine metabolism disruptions highlighted as crucial in Parkinson’s disease development

Study uncovers decision-making impairments linked to Parkinson's drug

Study uncovers decision-making impairments linked to Parkinson's drug

Breakthrough research reveals key role of melatonin receptor in REM sleep

Breakthrough research reveals key role of melatonin receptor in REM sleep

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.